$28.440
+3.254 (+11.44%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
CUE-Prognose durch Analyse ähnlicher Charts
Alphio's CUE stock price prediction model matches the current Cue Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.62 (-2.88%). The 1-week path is $27.38 (-3.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Cue Biopharma Inc-Aktien kaufen?
Cue Biopharma Inc is a good buy right now, primarily driven by its recent revenue growth of 175.44% year-to-date and a current price of $27.88, which is significantly lower than its 52-week high of $45.50. The company's recent appointment of a new CFO and advancements in its clinical pipeline, including the upcoming Phase 2 data for CUE-221, indicate strong potential for future growth. However, the main risk is the recent net loss of $153.07 million in Q2 2026, which raises concerns about financial stability.
CUE schloss am Tuesday bei $28.44, nachdem der Kurs +11.44% gestiegen ist
Cue Biopharma Inc (CUE) last closed at $28.44, gaining +11.44%. These facts feed the 1-day and 1-week CUE price prediction above.
Analystenkonsens
Cue Biopharma Inc (CUE): 1 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Cue Biopharma Inc (CUE) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf CUE am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für CUE
Historically the probability of a positive September return for CUE is 2.38%. January offers the highest probability of a positive month at 73.77%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.